TWST raises outlook after strong results; LIFE, GH, ALHC show growth; Carpenter reports mixed earnings.

Twist Bioscience (TWST) significantly raised its outlook after delivering results well above expectations, projecting triple-digit growth in orders. LIFE shares performed well following a strong earnings beat, while GH benefited from key approvals and expanded coverage supporting product growth. ALHC reported a strong quarter driven by membership growth and improved medical benefit ratio. However, Carpenter disappointed investors with mixed earnings despite a significant backlog. These developments highlight varied performance across companies in the quarter, with TWST and ALHC showing strong momentum.

Twist Bioscience (TWST) shares are currently trading at USD 163.00 on Pluang, showing a 1.97% increase in the last day. As of Oct 28, 2026 18:02 WIB, the stock has a market cap of $10.60 billion and a 52-week high of $205.00, with all Pluang order activity on the buy side.